Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $189.28 million. The enterprise value is $129.70 million.
Important Dates
The next estimated earnings date is Thursday, February 26, 2026, after market close.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRDF has 67.36 million shares outstanding. The number of shares has increased by 40.37% in one year.
| Current Share Class | 67.36M |
| Shares Outstanding | 67.36M |
| Shares Change (YoY) | +40.37% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 37.56% |
| Float | 65.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 377.81 |
| Forward PS | 537.02 |
| PB Ratio | 3.86 |
| P/TBV Ratio | 3.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 258.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.20 |
| Quick Ratio | 4.14 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -102.71% and return on invested capital (ROIC) is -66.55%.
| Return on Equity (ROE) | -102.71% |
| Return on Assets (ROA) | -52.99% |
| Return on Invested Capital (ROIC) | -66.55% |
| Return on Capital Employed (ROCE) | -109.44% |
| Revenue Per Employee | $15,182 |
| Profits Per Employee | -$1.53M |
| Employee Count | 33 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.54% in the last 52 weeks. The beta is 1.40, so CRDF's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -17.54% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 2.72 |
| Relative Strength Index (RSI) | 53.09 |
| Average Volume (20 Days) | 969,074 |
Short Selling Information
The latest short interest is 15.65 million, so 23.24% of the outstanding shares have been sold short.
| Short Interest | 15.65M |
| Short Previous Month | 16.14M |
| Short % of Shares Out | 23.24% |
| Short % of Float | 23.82% |
| Short Ratio (days to cover) | 14.61 |
Income Statement
In the last 12 months, CRDF had revenue of $501,000 and -$50.45 million in losses. Loss per share was -$0.79.
| Revenue | 501,000 |
| Gross Profit | -39.47M |
| Operating Income | -53.71M |
| Pretax Income | -50.42M |
| Net Income | -50.45M |
| EBITDA | -53.33M |
| EBIT | -53.71M |
| Loss Per Share | -$0.79 |
Full Income StatementBalance Sheet
The company has $60.59 million in cash and $1.01 million in debt, with a net cash position of $59.58 million or $0.88 per share.
| Cash & Cash Equivalents | 60.59M |
| Total Debt | 1.01M |
| Net Cash | 59.58M |
| Net Cash Per Share | $0.88 |
| Equity (Book Value) | 48.79M |
| Book Value Per Share | 0.73 |
| Working Capital | 47.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$42.22 million and capital expenditures -$44,000, giving a free cash flow of -$42.27 million.
| Operating Cash Flow | -42.22M |
| Capital Expenditures | -44,000 |
| Free Cash Flow | -42.27M |
| FCF Per Share | -$0.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -10,719.56% |
| Pretax Margin | -10,064.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.37% |
| Shareholder Yield | -40.37% |
| Earnings Yield | -26.65% |
| FCF Yield | -22.33% |
Analyst Forecast
The average price target for CRDF is $10.83, which is 285.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.83 |
| Price Target Difference | 285.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 178.10% |
| EPS Growth Forecast (5Y) | -15.11% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.
| Last Split Date | Feb 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
CRDF has an Altman Z-Score of -3.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.02 |
| Piotroski F-Score | 1 |
